Duality Biotherapeutics Inc. has addressed the recent fluctuation in the trading price and volume of its shares on the Stock Exchange of Hong Kong. The company's board confirms that the information in a recent press article does not constitute inside information and that they are not aware of any undisclosed information that would explain the price movement. The operations of the company remain normal, and shareholders are advised to exercise caution when dealing in the company's securities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief on June 10, 2025, and is solely responsible for the information contained therein.
Comments